Ad www.AngelOne.in
FREE Account Opening + Zero AMC Fees* + MutualFund SIP1
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Ad www.AngelOne.in
Right Issue Status: Closed [7th Dec 2022 to 19th Dec 2022]
Ajooni Biotech Limited offers Right Issue size of Rs 29.02 Cr opening subscription from 07 Dec 2022 to 15 Dec 2015. The company issues 29 right equity shares for every 30 fully paid-up equity share held on the record date, Nov 25, 2022. The face value of a share is Rs. 2 per share and the right issue price is fixed at Rs.6 per share. Stay updated with us to know more about the Ajooni Biotech Limited Right Issue Details 2022 including issue size, right issue entitlement, terms of payment, and more.
The details of the objects of the Issue are set out below:
1. TO PART FINANCE WORKING CAPITAL REQUIREMENTS OF THE COMPANY.
2. TO FINANCE THE GENERAL CORPORATE PURPOSE.
| Ajooni Biotech Issue Details | Values |
|---|---|
| Category | RightIssue |
| Right Issue Issue Size (Shares) | 4.84 Cr Shares |
| Right Issue Issue Size (Amount) | ₹29.02 Cr |
| Face Value | ₹2 Per Equity Share |
| Right Issue - Issue Price | ₹6 per share |
| Right Issue Record Date | 25th Nov 2022 |
| Right Issue Entitlement | 29 Equity Shares for every 30 Equity Shares held as on record date |
| Right Issue Terms of payment | The full amount of Issue Price Rs. 6 per Rights Equity Share is payable on Application. |
| Listing At | NSE |
| BSE Code | |
| NSE Code | AJOONI |
In this section we have covered all important dates related to Ajooni Biotech Right Issue. Dates are updated as they are announced. The most noted dates are Right Issue start date and Right Issue end date, which one should use to participate in Right Issue.
| Right Issue Activity | Date |
|---|---|
| Right Issue Issue Open Date | 7th Dec 2022 |
| Right Issue Issue Close Date | 19th Dec 2022 |
| Basis of Allotment Finalisation Date* | 23rd Dec 2022 |
| Refunds Initiation* | 9th Dec 2022 |
| Credit of Shares to Demat Account* | 27th Dec 2022 |
| Right Issue Listing Date* | 28th Dec 2022 |
* - Tentative Dates
Zerodha Trade@20
AJOONI Biotech Limited was incorporated in 2010 and It is a pioneer, innovator and leader in the production of animal feed. It's priorities are the quality, safety, innovations in production process, as well as excellent services provides to customers. With its own feed range, AJOONI is a rising key player in Animal Feed and aquaculture industry. AJOONI tends to be a good partner to all farmers. Their expert shares their expertise and many years of experience, propose a program of diet and gives the best recommendation for optimal growth and progress of the livestock.
The company's product portfolio includes (i) Cattle Feeds such as Milk Boosters, Natural Calf Starters, Energy products etc. and (ii) Feed Supplements.
To further validate and test its research results in practice, Ajooni engaged professionals from the reputed Universities, Institutions and research farms Collaboration and partnerships are a pre-requisite for speeding up the overall innovation development cycle. They always exploring and look forward to have collaborations and Joint ventures with world leaders from across globe. AJOONI's R&D activities focus on all steps from evaluating nutritional needs to production intended for sales.
Past performance and financial results of Ajooni Biotech.
| Period Ended | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 31-Mar-20 | 2.31 | 40.09 | 0.35 |
| 31-Mar-21 | 28.03 | 51.06 | 0.37 |
| 31-Mar-22 | 29.02 | 74.08 | 1.05 |
| Amount in ₹ Crore | |||
The table below is live update of Right Issue bidding details from NSE and BSE.
Ajooni Biotech Right Issue Offer Document (Letter of Offer) >>Document
Ajooni Biotech Right Issue Offer Document (Letter of Offer) >>Ajooni Biotech Right Issue Red Herring Prospectus is not yet available.
Ajooni Biotech Right Issue Online Application (Registrar & Transfer Agent) >>Online Application
Ajooni Biotech Right Issue Online Application (Registrar & Transfer Agent) >>Ajooni Biotech Right Issue RTA information is not yet available.
Last Updated on 2023-02-14T23:30:57+00:00
